FDA Inspection 1043586 — Huntington Reproductive Center Medical Group
The FDA completed an inspection of Huntington Reproductive Center Medical Group on January 19, 2018 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 19, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Los Angeles, CA (United States)